Active Genetics & Molecular Biology Cells, Biochemistry & Physiology

Defining the epigenetic principles that instruct the development of human embryos

In plain English

AI plain-English summary

Every human embryo begins as a blank slate of identical cells, and within 14 days those cells must decide whether to become the body, the placenta, or the support tissues that hold everything together. This research aims to uncover the epigenetic switches—chemical marks on DNA and the proteins that read them—that guide those first critical decisions. The problem is that scientists know very little about how these molecular instructions work in actual human embryos. Studying the first two weeks of development is technically extremely difficult, so most knowledge comes from animal models or lab-grown cell clusters that may not behave like real embryos. This leaves a fundamental gap in understanding how a single fertilised egg transforms into a structured, multi-layered organism. This is fundamental science. If successful, it will reveal the core principles that govern human development at its very start. That knowledge could eventually improve fertility treatments, explain why some embryos fail to implant, or shed light on why certain developmental disorders arise. Past discoveries in epigenetics have already transformed cancer treatment and regenerative medicine; this work lays a similar foundation for understanding the earliest moments of human life.

View original technical description
Epigenetic processes create opportunities in development for safeguarding and directing cell state, particularly by the activity of Polycomb proteins and associated histone modifications. Determining how these mechanisms control cellular plasticity and lineage decisions in human embryos has fundamental biological importance with wide-reaching clinical implications. However, progress has been hampered by challenges associated with examining histone modifications over the first 14 days of human embryo development. This has led to a critical knowledge gap about how epigenetic mechanisms control the development of early human embryos, which we will directly address in this research programme. First, we will determine the epigenetic basis of developmental plasticity in preimplantation human embryogenesis by examining the dynamics of histone modification changes and by modulating Polycomb activity that we predict will disable cellular plasticity at these development stages. Second, using a novel assembloid system to support the faithful development of postimplantation human embryos, we will investigate the establishment and robustness of multilineage priming mechanisms in early postimplantation development. Third, we will test our mechanistic leads on a new role for specific Polycomb complexes in safeguarding epiblast transitions. Altogether, this programme will make vital advances in our understanding of the molecular principles that instruct early human embryogenesis.

View the original record at the funder ↗

Researchers

Peter Rugg-Gunn (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Epigenetic regulation of lineage competence in human pluripotent stem cells
Epigenetic regulation of cell fate during early mammalian development
Promoter-associated histone modifications and establishment of the developmental gene expression program during early embryogenesis
Principles of human development and germ cell program
Development of a chromatin immunoprecipitation protocol applicable to small cell populations and its application to embryo research.

Original classification

Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.